§ 601.50. Confidentiality of data and information in an investigational new drug notice for a biological product.
106 words·~1 min read·
/us/cfr/t21/s§ 601.50·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)The existence of an IND notice for a biological product will not be disclosed by the Food and Drug Administration unless it has previously been publicly disclosed or acknowledged.
(b)The availability for public disclosure of all data and information in an IND file for a biological product shall be handled in accordance with the provisions established in § 601.51.
(c)Notwithstanding the provisions of § 601.51, the Food and Drug Administration shall disclose upon request to an individual on whom an investigational biological product has been used a copy of any adverse reaction report relating to such use. [39 FR 44656, Dec. 24, 1974]
Connections1 cite this
Cited by 1 section
register
Citation graph
cites case law
§ 601.50
Confidentiality of data and information in an investigational new drug notice for a biological product.
Fed. Reg.×1
Cites 0Cited by 1 across 1 source